Novan Inc. (NOVNQ)

Market Cap	2.80K
Revenue (ttm)	24.92M
Net Income (ttm)	-32.05M
Shares Out	n/a
EPS (ttm)	-1.32
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.0730
Day's Range	n/a
52-Week Range	n/a
Beta	-0.00
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NOVNQ

NVN Liquidation, Inc., a medical dermatology company, focuses on developing and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate ...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Sep 21, 2016
• Employees: 90
• Stock Exchange: OTCMKTS
• Ticker Symbol: NOVNQ

Financial Performance

In 2022, NOVNQ's revenue was $23.68 million, an increase of 700.61% compared to the previous year's $2.96 million. Losses were -$31.31 million, 5.45% more than in 2021.